Patents by Inventor Raffaello Pompei

Raffaello Pompei has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrrole compounds as inhibitors of mycobacteria, synthesis thereof and intermediates thereto
    Patent number: 8304410
    Abstract: The present invention relates to compounds having formula 3 as well as the synthesis, intermediates and methods of using the same.
    Type: Grant
    Filed: September 25, 2008
    Date of Patent: November 6, 2012
    Assignees: Università degli Studi di Roma “La Sapienza”, Università degli Studi di Siena
    Inventors: Mariangela Biava, Giulio Cesare Porretta, Raffaello Pompei, Maurizio Botta, Fabrizio Manetti, Alessandro De Logu
  • Derivatives of 1-{[1,5-bis(4-chlorophenyl)-2-methyl-1H-pyrrol-3-yl]methyl}-4-methylpiperazine, synthesis process and uses thereof
    Patent number: 8012970
    Abstract: The present invention concerns pyrrole compounds, derivatives of 1-{[1,5-bis(4-chlorophenyl)-2-methyl-1H-pyrrol-3-yl]methyl}-4-methylpiperazine (BM212). The invention concerns the use of the described compounds as antitubercular agents having high activity and low toxicity and process to obtain intermediates and final compounds.
    Type: Grant
    Filed: February 23, 2011
    Date of Patent: September 6, 2011
    Assignee: Universta' Degli Studi di Siena
    Inventors: Mariangela Biava, Fabrizio Manetti, Delia Deidda, Raffaello Pompei, Maurizio Botta, Giulio Cesare Porretta
  • Derivatives of 1--4-methylpiperazine, synthesis process and uses thereof
    Publication number: 20110144109
    Abstract: The present invention concerns pyrrole compounds, derivatives of 1-{[1,5-bis(4-chlorophenyl)-2-methyl-1H-pyrrol-3-yl]methyl}-4-methylpiperazine (BM212). The invention concerns the use of the described compounds as antitubercular agents having high activity and low toxicity and process to obtain intermediates and final compounds.
    Type: Application
    Filed: February 23, 2011
    Publication date: June 16, 2011
    Inventors: Mariangela BIAVA, Fabrizio MANETTI, Delia DEIDDA, Raffaello POMPEI, Maurizio BOTTA, Giulio Cesare PORRETTA
  • Derivatives of 1-{[1,5-bis(4-chlorophenyl)-2-methyl-1H-pyrrol-3-yl] methyl}-4-methylpiperazine, synthesis process and uses thereof
    Patent number: 7910581
    Abstract: The present invention concerns pyrrole compounds, derivatives of 1-{[1,5-bis(4-chlorophenyl)-2-methyl-1H-pyrrol-3-yl]methyl}-4-methylpiperazine (BM212). The invention concerns the use of the described compounds as antitubercular agents having high activity and low toxicity and process to obtain intermediates and final compounds.
    Type: Grant
    Filed: March 3, 2006
    Date of Patent: March 22, 2011
    Inventors: Mariangela Biava, Fabrizio Manetti, Delia Deidda, Raffaello Pompei, Maurizio Botta, Giulio Cesare Porretta
  • PYRROLE COMPOUNDS AS INHIBITORS OF MYCOBACTERIA, SYNTHESIS THEREOF AND INTERMEDIATES THERETO
    Publication number: 20100197672
    Abstract: The present invention relates to a compound having the general formula (3): synthesis, intermediates and uses thereof.
    Type: Application
    Filed: September 25, 2008
    Publication date: August 5, 2010
    Applicants: UNIVERSITA DEGLI STUDI DI ROMA "LA SAPIENZA", UNIVERSITA DEGLI STUDI DI SIENA
    Inventors: Mariangela Biava, Giulio Cesare Porretta, Raffaello Pompei, Maurizio Botta, Fabrizio Manetti, Alessandro De Logu
  • Derivatives of 1--4-methylpiperazine, synthesis process and uses thereof
    Publication number: 20090281094
    Abstract: The present invention concerns pyrrole compounds, derivatives of 1-{[1,5-bis(4-chlorophenyl)-2-methyl-1H-pyrrol-3-yl]methyl}-4-methylpiperazine (BM212). The invention concerns the use of the described compounds as antitubercular agents having high activity and low toxicity and process to obtain intermediates and final compounds.
    Type: Application
    Filed: March 3, 2006
    Publication date: November 12, 2009
    Inventors: Mariangela Biava, Fabrizio Manetti, Delia Deidda, Raffaello Pompei, Maurizio Botta, Giulio Cesare Porretta
  • Vector for site-specific integration of heterologous dna sequences into metilotrophic yeasts
    Publication number: 20040241829
    Abstract: The present invention is related to plasmid vectors for site-specific integration of heterologous DNA sequences in multiple copies into metilotrophic yeasts. A process for the expression of recombinant proteins based on the use of the present vectors and microorganisms derived from transformation with the vectors of the present invention are also described.
    Type: Application
    Filed: July 8, 2004
    Publication date: December 2, 2004
    Inventors: Gian Maria Rossolini, Maria Letizia Riccio, Cesira Galeotti, Raffaello Pompei
  • Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity
    Patent number: 6329339
    Abstract: This invention relates to pharmaceutical compositions of and methods of treating viral infections with a synergistic combination of glycyrrhizic acid and either a lactoferrin or a lysozyme.
    Type: Grant
    Filed: January 18, 2000
    Date of Patent: December 11, 2001
    Assignee: Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A.
    Inventors: Raffaello Pompei, Mario Pinza